Discover 3,059 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Pennsylvania provides numerous options to healthy volunteers looking to take part in paid research studies, as well as participants looking for condition-specific trials. Research hubs in Philadelphia, Pittsburgh, and Allentown are actively recruiting participants, giving access to groundbreaking treatments and quality healthcare.
Filter
1
Filter results
Results: 3,059
DFT383 in Pediatric Participants With Nephropathic Cystinosis
for
Nephropathic Cystinosis
Location: Philadelphia PA, Atlanta GA, Houston TX, Phoenix AZ,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 2 - 5
Code: NCT06910813
Phase 1, Phase 2, Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
for
Hepatocellular Cancer, Squamous-Cell Non-Small Cell Lung Cancer
Location: New York NY, Philadelphia PA, Nashville TN, Chicago IL,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06858813
Phase 1, Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Saint John, Bath ME, Portland ME, Scarborough ME,
Sponsor: NRG Oncology
Sex: Male
Age: 18+
Code: NCT05946213
Phase 3, Recruiting
Left vs Left Randomized Clinical Trial
for
Heart Failure, Heart Failure With Reduced Ejection Fraction,
Location: Halifax, Boston MA, Hartford CT, New Haven CT, Quebec,
Sponsor: Baylor College of Medicine
Sex: All
Age: 18+
Code: NCT05650658
Recruiting
Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments
for
Depression, OCD, Anxiety Depression
Location: Malvern PA
Sponsor: Neuronetics
Sex: All
Age: 5 - 70+
Code: NCT06997549
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Rett Syndrome Registry
for
Rett Syndrome, Rett Syndrome, Atypical, Genetic Disease,
Location: Boston MA, Philadelphia PA, Baltimore MD,
Sponsor: International Rett Syndrome Foundation
Sex: All
Age: 0 - 70+
Code: NCT05432349
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
for
Pyoderma Gangrenosum
Location: Boston MA, Lebanon NH, Quebec, Lake Success NY,
Sponsor: LEO Pharma
Sex: All
Age: 18+
Code: NCT06624670
Phase 3, Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
for
Pediatric Migraine
Location: East Greenwich RI, Cromwell CT, Commack NY, Stamford CT,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04649242
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata
for
Alopecia Areata
Location: New York NY, Upper Saint Clair PA, Charlotte NC,
Sponsor: AnaptysBio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT05205070
Phase 2, Recruiting
US National OCS Heart Perfusion (OHP) Registry
for
Heart Transplant
Location: Boston MA, New Haven CT, Valhalla NY, The Bronx NY,
Sponsor: TransMedics
Sex: All
Age: 0+
Code: NCT05915299
Recruiting
STimulation to Activate RespIration
for
ARDS (Moderate or Severe), AHRF,
Location: Philadelphia PA, Toronto, Columbia SC, Cleveland OH,
Sponsor: Lungpacer Medical Inc.
Sex: All
Age: 18+
Code: NCT06832306
Recruiting
Transition to Cardiac Rehabilitation (T2CR) to Address Barriers of Multimorbidity and Frailty
for
Cardiovascular Diseases, Cardiac Rehabilitation,
Location: Boston MA, Pittsburgh PA
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT06244199
Recruiting
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
for
Mitral Valve Regurgitation
Location: Boston MA, Hartford CT, New Haven CT, Roslyn NY,
Sponsor: Medtronic Cardiovascular
Sex: All
Age: 18+
Code: NCT03242642
Recruiting
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer